Ernest I. Tan

Perth, WA, AU 
Perth, WA, AU 

Overview

Ernest Tan practices practicing medicine in Perth, Australia.

His clinical expertise encompasses Punctate Porokeratosis and Atopic Dermatitis.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Perth, WA, Australia
Other Locations
Nedlands, WA, Australia
St. Leonards, NSW, Australia
Victoria Park, WA, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
View 2 Less Clinical Trials

9 Total Publications

Appropriate Use of Mohs Micrographic Surgery: A Survey of Australasian Mohs Dermatologists.
Appropriate Use of Mohs Micrographic Surgery: A Survey of Australasian Mohs Dermatologists.
Journal: The Australasian journal of dermatology
Published: February 05, 2026

Frequently Asked Questions about Ernest I. Tan

Is Ernest I. Tan a top-rated expert for Punctate Porokeratosis?

MediFind is an objective health platform that identifies experts based on real-world data. Ernest I. Tan is classified as an Experienced expert for Punctate Porokeratosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ernest I. Tan participate in research or clinical trials?

Yes. Ernest I. Tan has published 9 articles and abstracts on conditions like Punctate Porokeratosis. You can view a list of Ernest I. Tan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tan's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile